Skip to main content
. 2024 Mar 13;15:129–140. doi: 10.2147/JBM.S443312

Table 2.

Clinical Characteristics of Study Participants at JMC, South-west Ethiopia from January 14 to February 28, 2021 (n = 288)

Variables Frequency Percent (%)
Parity Primiparous 108 37.5
Multiparous 180 62.5
Birth interval (n = 180) ≤ 2 64 35.6
>2 116 64.4
ANC follow up Yes 260 90.3
No 28 9.7
Iron and folic acid supplementation Yes 240 83.3
No 48 16.7
Trimester iron or folic acid supplementation started (n = 240) First trimester 84 35
Second Trimester 128 53.3
Third trimester 28 11.7
History of miscarriage Yes 19 6.6
No 269 93.4
History of excess menstrual bleeding Yes 33 11.5
No 255 88.5
History of vaginal bleeding during pregnancy Yes 29 10.1
No 259 89.9
History of intestinal parasite infection during pregnancy Yes 48 16.7
No 240 83.3
History of malaria infection during pregnancy Yes 20 6.9
No 268 93.1
Rhesus incompatibility managed Yes 8 2.8
No 280 97.2
ABO incompatibility Yes 47 16.3
No 241 83.7
Current mode of delivery Spontaneous vaginal 210 72.9
Cesarean section 78 27.1